CONTEXT: Recent studies suggest that copy number variation in the human genome is extensive and may play an important role in susceptibility to disease, including neuropsychiatric disorders such as schizophrenia and autism. The possible involvement of copy number variants (CNVs) in bipolar disorder has received little attention to date. OBJECTIVES: To determine whether large (>100,000 base pairs) and rare (found in <1% of the population) CNVs are associated with susceptibility to bipolar disorder and to compare with findings in schizophrenia. DESIGN: A genome-wide survey of large, rare CNVs in a case-control sample using a high-density microarray. SETTING: The Wellcome Trust Case Control Consortium. PARTICIPANTS: There were 1697 cases of bipolar disorder and 2806 nonpsychiatric controls. All participants were white UK residents. MAIN OUTCOME MEASURES: Overall load of CNVs and presence of rare CNVs. RESULTS: The burden of CNVs in bipolar disorder was not increased compared with controls and was significantly less than in schizophrenia cases. The CNVs previously implicated in the etiology of schizophrenia were not more common in cases with bipolar disorder. CONCLUSIONS: Schizophrenia and bipolar disorder differ with respect to CNV burden in general and association with specific CNVs in particular. Our data are consistent with the possibility that possession of large, rare deletions may modify the phenotype in those at risk of psychosis: those possessing such events are more likely to be diagnosed as having schizophrenia, and those without them are more likely to be diagnosed as having bipolar disorder.
CONTEXT: Recent studies suggest that copy number variation in the human genome is extensive and may play an important role in susceptibility to disease, including neuropsychiatric disorders such as schizophrenia and autism. The possible involvement of copy number variants (CNVs) in bipolar disorder has received little attention to date. OBJECTIVES: To determine whether large (>100,000 base pairs) and rare (found in <1% of the population) CNVs are associated with susceptibility to bipolar disorder and to compare with findings in schizophrenia. DESIGN: A genome-wide survey of large, rare CNVs in a case-control sample using a high-density microarray. SETTING: The Wellcome Trust Case Control Consortium. PARTICIPANTS: There were 1697 cases of bipolar disorder and 2806 nonpsychiatric controls. All participants were white UK residents. MAIN OUTCOME MEASURES: Overall load of CNVs and presence of rare CNVs. RESULTS: The burden of CNVs in bipolar disorder was not increased compared with controls and was significantly less than in schizophrenia cases. The CNVs previously implicated in the etiology of schizophrenia were not more common in cases with bipolar disorder. CONCLUSIONS: Schizophrenia and bipolar disorder differ with respect to CNV burden in general and association with specific CNVs in particular. Our data are consistent with the possibility that possession of large, rare deletions may modify the phenotype in those at risk of psychosis: those possessing such events are more likely to be diagnosed as having schizophrenia, and those without them are more likely to be diagnosed as having bipolar disorder.
Authors: Herbert M Lachman; Erika Pedrosa; Oriana A Petruolo; Melissa Cockerham; Alexander Papolos; Tomas Novak; Demitri F Papolos; Pavla Stopkova Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2007-04-05 Impact factor: 3.568
Authors: Robin M Murray; Pak Sham; Jim Van Os; Jolanta Zanelli; Mary Cannon; Colm McDonald Journal: Schizophr Res Date: 2004-12-01 Impact factor: 4.939
Authors: Bin Xu; J Louw Roos; Shawn Levy; E J van Rensburg; Joseph A Gogos; Maria Karayiorgou Journal: Nat Genet Date: 2008-05-30 Impact factor: 38.330
Authors: Regina E Ensenauer; Adewale Adeyinka; Heather C Flynn; Virginia V Michels; Noralane M Lindor; D Brian Dawson; Erik C Thorland; Cindy Pham Lorentz; Jennifer L Goldstein; Marie T McDonald; Wendy E Smith; Elba Simon-Fayard; Alan A Alexander; Anita S Kulharya; Rhett P Ketterling; Robin D Clark; Syed M Jalal Journal: Am J Hum Genet Date: 2003-10-02 Impact factor: 11.025
Authors: Dan Rujescu; Andres Ingason; Sven Cichon; Olli P H Pietiläinen; Michael R Barnes; Timothea Toulopoulou; Marco Picchioni; Evangelos Vassos; Ulrich Ettinger; Elvira Bramon; Robin Murray; Mirella Ruggeri; Sarah Tosato; Chiara Bonetto; Stacy Steinberg; Engilbert Sigurdsson; Thordur Sigmundsson; Hannes Petursson; Arnaldur Gylfason; Pall I Olason; Gudmundur Hardarsson; Gudrun A Jonsdottir; Omar Gustafsson; Ragnheidur Fossdal; Ina Giegling; Hans-Jürgen Möller; Annette M Hartmann; Per Hoffmann; Caroline Crombie; Gillian Fraser; Nicholas Walker; Jouko Lonnqvist; Jaana Suvisaari; Annamari Tuulio-Henriksson; Srdjan Djurovic; Ingrid Melle; Ole A Andreassen; Thomas Hansen; Thomas Werge; Lambertus A Kiemeney; Barbara Franke; Joris Veltman; Jacobine E Buizer-Voskamp; Chiara Sabatti; Roel A Ophoff; Marcella Rietschel; Markus M Nöthen; Kari Stefansson; Leena Peltonen; David St Clair; Hreinn Stefansson; David A Collier Journal: Hum Mol Genet Date: 2008-10-22 Impact factor: 6.150
Authors: V Moskvina; N Craddock; P Holmans; I Nikolov; J S Pahwa; E Green; M J Owen; M C O'Donovan Journal: Mol Psychiatry Date: 2008-12-09 Impact factor: 15.992
Authors: A E Baum; N Akula; M Cabanero; I Cardona; W Corona; B Klemens; T G Schulze; S Cichon; M Rietschel; M M Nöthen; A Georgi; J Schumacher; M Schwarz; R Abou Jamra; S Höfels; P Propping; J Satagopan; S D Detera-Wadleigh; J Hardy; F J McMahon Journal: Mol Psychiatry Date: 2007-05-08 Impact factor: 15.992
Authors: A Carlo Altamura; Marta Serati; Alessandra Albano; Riccardo A Paoli; Ira D Glick; Bernardo Dell'Osso Journal: Eur Arch Psychiatry Clin Neurosci Date: 2011-02-18 Impact factor: 5.270
Authors: Junghee Lee; Lori Altshuler; David C Glahn; David J Miklowitz; Kevin Ochsner; Michael F Green Journal: Am J Psychiatry Date: 2013-03 Impact factor: 18.112